JW Lifescience Corporation

KOSE:A234080 Stock Report

Market Cap: ₩174.7b

JW Lifescience Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Sungnam Cha

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Solid Earnings Reflect JW Lifescience's (KRX:234080) Strength As A Business

Nov 24
Solid Earnings Reflect JW Lifescience's (KRX:234080) Strength As A Business

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Apr 20
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year

Mar 11
Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year

What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?

Feb 21
What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?

Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?

Feb 02
Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Jan 12
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?

Dec 23
Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?

Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?

Dec 23
Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?

How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?

Nov 27
How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?

CEO

Sungnam Cha

no data

Tenure

Sungnam Cha serves as Chief Executive Officer and Director at JW Lifescience Corporation.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:37
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

JW Lifescience Corporation is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimCape Investment & Securities Co., Ltd.
Tae Young LeeKB Securities Co., Ltd.
Changmin YoonShinhan Investment Corp.